These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12161062)

  • 1. Azanonaboranes [(RNH(2))B(8)H(11)NHR] as possible new compounds for use in boron neutron capture therapy.
    Bauer C; Gabel D; Dörfler U
    Eur J Med Chem; 2002 Aug; 37(8):649-57. PubMed ID: 12161062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of (aminoalkylamine)-N-aminoalkyl)azanonaborane(11) derivatives for boron neutron capture therapy.
    El-Zaria ME; Dörfler U; Gabel D
    J Med Chem; 2002 Dec; 45(26):5817-9. PubMed ID: 12477367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azanonaboranes containing imidazole derivatives for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
    El-Zaria ME; Genady AR; Gabel D
    Chemistry; 2006 Oct; 12(31):8084-9. PubMed ID: 16865752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron capture agent DAC-1.
    Tilly N; Olsson P; Hartman T; Coderre J; Makar M; Malmquist J; Sjöberg S; Pettersson J; Carlsson J; Glimelius B
    Radiother Oncol; 1996 Jan; 38(1):41-50. PubMed ID: 8850425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phthalocyanine-ortho-Carborane Conjugate for Boron Neutron Capture Therapy: Synthesis, Physicochemical Properties, and in vitro Tests.
    Nar I; Bortolussi S; Postuma I; Atsay A; Berksun E; Viola E; Ferrari C; Cansolino L; Ricciardi G; Donzello MP; Hamuryudan E
    Chempluschem; 2019 Apr; 84(4):345-351. PubMed ID: 31939222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy.
    Ono K; Masunaga SI; Kinashi Y; Takagaki M; Akaboshi M; Kobayashi T; Akuta K
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1081-6. PubMed ID: 8600091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined effect of electroporation and borocaptate in boron neutron capture therapy for murine solid tumors.
    Ono K; Kinashi Y; Suzuki M; Takagaki M; Masunaga SI
    Jpn J Cancer Res; 2000 Aug; 91(8):853-8. PubMed ID: 10965028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. closo-borane conjugated regulatory peptides retain high biological affinity: synthesis of closo-borane conjugated Tyr(3)-octreotate derivatives for BNCT.
    Betzel T; Hess T; Waser B; Reubi JC; Roesch F
    Bioconjug Chem; 2008 Sep; 19(9):1796-802. PubMed ID: 18712900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of monosubstituted functional derivatives of carboranes from 1-mercapto-ortho-carborane: 1-HOOC(CH(2))(n)S-1,2-C(2)B(10)H(11) and [7-HOOC(CH(2))(n)S-7,8-C(2)B(9)H(11)](-) (n = 1-4).
    Stogniy MY; Sivaev IB; Petrovskii PV; Bregadze VI
    Dalton Trans; 2010 Feb; 39(7):1817-22. PubMed ID: 20449427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cellular studies of porphyrin-cobaltacarborane conjugates.
    Hao E; Jensen TJ; Courtney BH; Vicente MG
    Bioconjug Chem; 2005; 16(6):1495-502. PubMed ID: 16287247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
    Masunaga S; Nagasawa H; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Int J Hyperthermia; 2006 Jun; 22(4):287-99. PubMed ID: 16754350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
    Genady AR
    Eur J Med Chem; 2009 Jan; 44(1):409-16. PubMed ID: 18407378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics in melanoma-bearing mice of 5-dihydroxyboryl-6-propyl-2-thiouracil (BPTU), a candidate compound for boron neutron capture therapy.
    Verrijk R; Smolders IJ; Huiskamp R; Gavin PR; Philipp KH; Begg AC
    Br J Cancer; 1994 Apr; 69(4):641-7. PubMed ID: 8142252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carborane-conjugated 2-quinolinecarboxamide ligands of the translocator protein for boron neutron capture therapy.
    Cappelli A; Valenti S; Mancini A; Giuliani G; Anzini M; Altieri S; Bortolussi S; Ferrari C; Clerici AM; Zonta C; Carraro F; Filippi I; Giorgi G; Donati A; Ristori S; Vomero S; Concas A; Biggio G
    Bioconjug Chem; 2010 Dec; 21(12):2213-21. PubMed ID: 21087014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal boron delivery for neutron capture therapy.
    Nakamura H
    Methods Enzymol; 2009; 465():179-208. PubMed ID: 19913168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells.
    Lindström P; Olsson P; Malmqvist J; Pettersson J; Lemmen P; Werner B; Sjöberg S; Olin A; Carlsson J
    Anticancer Drugs; 1994 Feb; 5(1):43-52. PubMed ID: 8186429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomes as drug delivery vehicles for boron agents.
    Hawthorne MF; Shelly K
    J Neurooncol; 1997 May; 33(1-2):53-8. PubMed ID: 9151223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of sulfhydrylborane-dextran conjugates for boron neutron capture therapy.
    Holmberg A; Meurling L
    Bioconjug Chem; 1993; 4(6):570-3. PubMed ID: 8305528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
    Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
    J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.